223 related articles for article (PubMed ID: 28109175)
1. Langerhans cell markers CD1a and CD207 are the most rapidly responding genes in lesional psoriatic skin following adalimumab treatment.
Raaby L; Rosada C; Langkilde A; Lauridsen KL; Vinter H; Ommen P; Kjellerup RB; Johansen C; Iversen L
Exp Dermatol; 2017 Sep; 26(9):804-810. PubMed ID: 28109175
[TBL] [Abstract][Full Text] [Related]
2. Effects of adalimumab, etanercept and ustekinumab on the expression of psoriasin (S100A7) in psoriatic skin.
D'Amico F; Trovato C; Skarmoutsou E; Rossi GA; Granata M; Longo V; Gangemi P; Pettinato M; Mazzarino MC
J Dermatol Sci; 2015 Oct; 80(1):38-44. PubMed ID: 26276441
[TBL] [Abstract][Full Text] [Related]
3. Biological therapy downregulates the heterodimer S100A8/A9 (calprotectin) expression in psoriatic patients.
D'Amico F; Granata M; Skarmoutsou E; Trovato C; Lovero G; Gangemi P; Longo V; Pettinato M; Mazzarino MC
Inflamm Res; 2018 Jul; 67(7):609-616. PubMed ID: 29605872
[TBL] [Abstract][Full Text] [Related]
4. Pathway Analysis of Skin from Psoriasis Patients after Adalimumab Treatment Reveals New Early Events in the Anti-Inflammatory Mechanism of Anti-TNF-α.
Langkilde A; Olsen LC; Sætrom P; Drabløs F; Besenbacher S; Raaby L; Johansen C; Iversen L
PLoS One; 2016; 11(12):e0167437. PubMed ID: 28005985
[TBL] [Abstract][Full Text] [Related]
5. The tumour necrosis factor-alpha inhibitor adalimumab rapidly reverses the decrease in epidermal Langerhans cell density in psoriatic plaques.
Gordon KB; Bonish BK; Patel T; Leonardi CL; Nickoloff BJ
Br J Dermatol; 2005 Nov; 153(5):945-53. PubMed ID: 16225604
[TBL] [Abstract][Full Text] [Related]
6. Changes in mRNA expression precede changes in microRNA expression in lesional psoriatic skin during treatment with adalimumab.
Raaby L; Langkilde A; Kjellerup RB; Vinter H; Khatib SH; Hjuler KF; Johansen C; Iversen L
Br J Dermatol; 2015 Aug; 173(2):436-47. PubMed ID: 25662483
[TBL] [Abstract][Full Text] [Related]
7. Preferential inhibition of the mRNA expression of p38 mitogen-activated protein kinase regulated cytokines in psoriatic skin by anti-TNFα therapy.
Johansen C; Vinter H; Soegaard-Madsen L; Olsen LR; Steiniche T; Iversen L; Kragballe K
Br J Dermatol; 2010 Dec; 163(6):1194-204. PubMed ID: 20846304
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 20 protein locates to distinct mononuclear cells in psoriatic skin.
Bech R; Otkjaer K; Birkelund S; Vorup-Jensen T; Agger R; Johansen C; Iversen L; Kragballe K; Rømer J
Exp Dermatol; 2014 May; 23(5):349-52. PubMed ID: 24628979
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of Langerhans cell protein kinase C-beta isoenzyme expression in inflammatory and hyperplastic dermatoses.
Reynolds NJ; Yi JY; Fisher GJ; Cooper KD; Voorhees JJ; Griffiths CE
Br J Dermatol; 1995 Aug; 133(2):157-67. PubMed ID: 7547380
[TBL] [Abstract][Full Text] [Related]
10. The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study.
Vossen ARJV; Ardon CB; van der Zee HH; Lubberts E; Prens EP
Br J Dermatol; 2019 Aug; 181(2):314-323. PubMed ID: 30657173
[TBL] [Abstract][Full Text] [Related]
11. IL-12 secretion by Langerhans cells stimulated with Candida skin test reagent is mediated by dectin-1 in some healthy individuals.
Nakagawa M; Coleman HN; Wang X; Daniels J; Sikes J; Nagarajan UM
Cytokine; 2014 Feb; 65(2):202-9. PubMed ID: 24301038
[TBL] [Abstract][Full Text] [Related]
12. Efficacy comparison of ustekinumab between anti-tumor necrosis factor-α drug-naïve and anti-tumor necrosis factor-α drug-resistant Japanese psoriasis cases.
Takahashi N; Noda S; Taniguchi T; Adachi M
Int J Dermatol; 2015 Oct; 54(10):1194-8. PubMed ID: 26016819
[TBL] [Abstract][Full Text] [Related]
13. Effect of Adalimumab on Gene Expression Profiles of Psoriatic Skin and Blood.
Chow M; Lai K; Ahn R; Gupta R; Arron S; Liao W
J Drugs Dermatol; 2016 Aug; 15(8):988-94. PubMed ID: 27538000
[TBL] [Abstract][Full Text] [Related]
14. Stat3 activation in epidermal keratinocytes induces Langerhans cell activation to form an essential circuit for psoriasis via IL-23 production.
Nakajima K; Kataoka S; Sato K; Takaishi M; Yamamoto M; Nakajima H; Sano S
J Dermatol Sci; 2019 Feb; 93(2):82-91. PubMed ID: 30514663
[TBL] [Abstract][Full Text] [Related]
15. Langerin (CD207) staining in normal pediatric tissues, reactive lymph nodes, and childhood histiocytic disorders.
Chikwava K; Jaffe R
Pediatr Dev Pathol; 2004; 7(6):607-14. PubMed ID: 15630529
[TBL] [Abstract][Full Text] [Related]
16. BMPR1a Is Required for the Optimal TGFβ1-Dependent CD207
Hochgerner M; Bauer T; Zyulina V; Glitzner E; Warsi S; Konkel JE; Tam-Amersdorfer C; Chen W; Karlsson S; Sibilia M; Strobl H
J Invest Dermatol; 2022 Sep; 142(9):2446-2454.e3. PubMed ID: 35300973
[TBL] [Abstract][Full Text] [Related]
17. Anti-TNF-α Drugs Differently Affect the TNFα-sTNFR System and Monocyte Subsets in Patients with Psoriasis.
Gibellini L; De Biasi S; Bianchini E; Bartolomeo R; Fabiano A; Manfredini M; Ferrari F; Albertini G; Trenti T; Nasi M; Pinti M; Iannone A; Salvarani C; Cossarizza A; Pellacani G
PLoS One; 2016; 11(12):e0167757. PubMed ID: 27936119
[TBL] [Abstract][Full Text] [Related]
18. IL-4 Downregulates IL-1β and IL-6 and Induces GATA3 in Psoriatic Epidermal Cells: Route of Action of a Th2 Cytokine.
Onderdijk AJ; Baerveldt EM; Kurek D; Kant M; Florencia EF; Debets R; Prens EP
J Immunol; 2015 Aug; 195(4):1744-52. PubMed ID: 26170379
[TBL] [Abstract][Full Text] [Related]
19. [Expression of CD1a and CD207 in condyloma acuminatum epidermis].
Feng JY; Rao GZ; Liu YP; Li P; Cui R; Li JH; Liu JZ; Peng ZH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 May; 25(5):420-2. PubMed ID: 19426597
[TBL] [Abstract][Full Text] [Related]
20. Biological therapy induces expression changes in Notch pathway in psoriasis.
Skarmoutsou E; Trovato C; Granata M; Rossi GA; Mosca A; Longo V; Gangemi P; Pettinato M; D'Amico F; Mazzarino MC
Arch Dermatol Res; 2015 Dec; 307(10):863-73. PubMed ID: 26319047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
